BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38100938)

  • 1. Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study.
    Ter Welle-Butalid ME; van Osch L; van Bree BE; Vriens IJH; Derhaag JG; de Die-Smulders CEM; Tjan-Heijnen VCG; van Golde RJT
    Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():27-31. PubMed ID: 38100938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: a qualitative study.
    Bayefsky MJ; Sampson A; Blakemore JK; Jalili D; Lilly AG; Fino ME; Quinn GP
    Hum Reprod; 2024 Jan; 39(1):147-153. PubMed ID: 37944107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counseling young women with early breast cancer on fertility preservation.
    Ter Welle-Butalid MEE; Vriens IJHI; Derhaag JGJ; Leter EME; de Die-Smulders CEC; Smidt MM; van Golde RJTR; Tjan-Heijnen VCGV
    J Assist Reprod Genet; 2019 Dec; 36(12):2593-2604. PubMed ID: 31760547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preservation and preimplantation genetic assessment for women with breast cancer.
    Sciorio R; Anderson RA
    Cryobiology; 2020 Feb; 92():1-8. PubMed ID: 31863734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary breast cancer and fertility preservation outcomes.
    Arab S; Tulandi T; Buckett W
    J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of preimplantation genetic testing for aneuploidy in medically indicated fertility preservation.
    Blakemore JK; Trawick EC; Grifo JA; Goldman KN
    Fertil Steril; 2020 Feb; 113(2):408-416. PubMed ID: 31973902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.
    Arecco L; Blondeaux E; Bruzzone M; Ceppi M; Latocca MM; Marrocco C; Boutros A; Spagnolo F; Razeti MG; Favero D; Spinaci S; Condorelli M; Massarotti C; Goldrat O; Del Mastro L; Demeestere I; Lambertini M
    Hum Reprod; 2022 May; 37(5):954-968. PubMed ID: 35220429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.
    Mangiardi-Veltin M; Sebbag C; Rousset-Jablonski C; Ray-Coquard I; Berkach C; Laot L; Wang Y; Abdennebi I; Labrosse J; Sautter C; Toussaint A; Sablone L; Laas E; Khallouch S; Coussy F; Santulli P; Chapron C; Bobrie A; Jacot W; Sella N; Dumas E; Sénéchal-Davin C; Espie M; Giacchetti S; Maitrot L; Plu-Bureau G; Coutant C; Guerin J; Asselain B; Fumoleau P; Rodrigues M; Decanter C; Mailliez A; Delrieu L; Lemoine A; Jouannaud C; Houdre D; Reyal F; Hamy AS;
    Reprod Biomed Online; 2022 Jun; 44(6):1031-1044. PubMed ID: 35525718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of fertility preservation in patients with breast cancer.
    Ulrich ND; Raja NS; Moravek MB
    Best Pract Res Clin Obstet Gynaecol; 2022 Jun; 82():60-68. PubMed ID: 35120831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation.
    Loreti S; Darici E; Nekkebroeck J; Drakopoulos P; Van Landuyt L; De Munck N; Tournaye H; De Vos M
    Hum Reprod; 2024 Feb; 39(2):355-363. PubMed ID: 38145619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation among young breast cancer patients: A single-center experience in China.
    Wan Q; Han L; Liu J; Li H; Li Y; Long QM; Tan L; Li JJ
    Taiwan J Obstet Gynecol; 2021 Sep; 60(5):827-830. PubMed ID: 34507656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preservation in breast cancer patients.
    Rodgers RJ
    Minerva Ginecol; 2019 Jun; 71(3):196-206. PubMed ID: 31089071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.